The BSPED is pleased that the NICE consultation on AI in children and adults has recommended management in line with the BSPED guidance. As stakeholders, the BSPED clinical committee and BSPED Adrenal SIG had provided feedback on the guideline and had raised some areas of concerns. Some of these were addressed and some contentious areas remain. The BSPED clinical committee will review the final guideline in detail. The clinical committee will discuss this in the upcoming clinical committee meeting and liaise with the Adrenal SIG, to determine if BSPED would like to make specific recommendations regarding safe implementation of the guideline.

This final guideline has now been published on the NICE website along with the supporting evidence, tools and resources as well as all the stakeholder comments received during consultation and the responses to these comments.